Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-02-20 @ 6:03 PM
Study NCT ID:
NCT02004093
Status:
COMPLETED
Last Update Posted:
2014-12-04
First Post:
2013-12-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-03
First Submit QC Date:
None
Study First Post Date:
2013-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-07-31
Results First Submit QC Date:
None
Results First Post Date:
2014-12-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-25
Last Update Post Date:
2014-12-04
Last Update Post Date Type:
ESTIMATED